Evariant appoints Clay Ritchey as new chief executive officer

Evariant, the leading healthcare CRM data analytics platform, recently announced that it has appointed Clay Ritchey as CEO. William Moschella, Evariant’s co-founder and former CEO, will remain on the company’s board of directors and senior leadership team.

“This marks an important milestone for Evariant as we continue rapid growth and customer expansion,” said Moschella. “Clay shares my passion for enabling customer success and growth in the healthcare market and is the right person to lead Evariant through the next stage of hyper growth.”

Clay Ritchey has more than 20 years of experience driving growth and innovation in healthcare technology and services organizations. Most recently, Ritchey served as GM and Chief Marketing Officer of Imprivata, the Healthcare IT security leader. His leadership helped lead a successful IPO and topline growth of over 150 percent during his tenure. Prior to Imprivata, Ritchey was the Chief Executive Officer of private-equity held Equinox Healthcare, a post-acute healthcare services company. Before that, he held senior executive roles at Hill-Rom IT Solutions and Kronos Incorporated launching new products driving over $300 million of new revenue. Ritchey received his MBA from Harvard Business School and his BSEE, with Highest Distinction, from The Pennsylvania State University.

“Under Bill’s leadership, Evariant has pioneered technology solutions that have enabled leading healthcare systems to take the leap to cutting edge digital marketing methods delivering significant value and revenue growth for their organizations.” said Ritchey. “After hearing firsthand the success many of the most prestigious names in healthcare have had spurring growth and increasing market share, I have no doubt we’re ready to take the industry to the next level. I look forward to partnering with our customers and our talented teams to build on our tremendous success and continue to innovate and transform the way health systems attract and retain patients across the care continuum.”

“We’re just getting started with our journey, and I have never been more excited about the future of the company,” Moschella added, “Clay’s addition to the team will free up my time to focus on what I’m most passionate about: innovating with customers and working with our partners.” Moschella served as Evariant’s CEO for nine years and helped grow the company into a leading provider of healthcare CRM and analytics used by over 1,000 hospitals and more than 50 health systems.

“Evariant has continued to scale its business and operations by delivering industry-leading software that enables health systems to innovate how they communicate with their constituents,” commented board member Jason Kreuziger, a Vice President in the Merchant Banking Division of Goldman Sachs, which is an investor in Evariant. “The Company is well-positioned to capitalize on the commercial opportunity available today, and we look forward to working closely with Clay to leverage his experience in scaling healthcare marketing and technology businesses and lead Evariant on its path towards sustainable growth and profitability.”


Copyright © 2022 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Learning Opportunities

Featured Whitepapers

Featured Webinars